Page last updated: 2024-10-24

protein K63-linked deubiquitination

Definition

Target type: biologicalprocess

A protein deubiquitination process in which a K63-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is removed from a protein. [GOC:mah, PMID:19202061, PMID:19214193]

Protein K63-linked deubiquitination is a crucial regulatory mechanism in cellular processes, particularly in signal transduction, DNA repair, and inflammation. K63-linked polyubiquitination involves the attachment of ubiquitin molecules to a target protein via their lysine 63 residue, forming a chain that does not typically lead to proteasomal degradation. Instead, these chains act as signaling platforms, recruiting specific effector proteins and modulating the activity of the target protein. Deubiquitinases (DUBs) play a critical role in counteracting this process by removing K63-linked ubiquitin chains.

The process of K63-linked deubiquitination can be summarized in the following steps:

1. **Recognition and Binding:** DUBs possess specific domains that recognize and bind to K63-linked ubiquitin chains. These domains often exhibit high affinity for the unique structural features of K63 linkages.
2. **Cleavage of the Isopeptide Bond:** Once bound, the DUB catalytic domain cleaves the isopeptide bond between the ubiquitin molecule and the target protein or between adjacent ubiquitin molecules within the chain. This process is typically highly specific and involves the hydrolysis of the isopeptide bond.
3. **Release of Free Ubiquitin and Target Protein:** The cleavage event releases free ubiquitin molecules and the target protein, which can now function without the attached ubiquitin chains.

The functional consequences of K63-linked deubiquitination vary depending on the target protein and the cellular context. For instance, in signaling pathways, DUBs can remove K63-linked ubiquitin chains from receptor proteins, thereby terminating the signal transduction cascade. In DNA repair, DUBs are involved in the removal of K63-linked ubiquitin from DNA repair proteins, facilitating the repair process. In inflammation, DUBs can modulate the activity of inflammatory signaling molecules by removing K63-linked ubiquitin chains.

The regulation of K63-linked deubiquitination is tightly controlled, and dysregulation can lead to various diseases, including cancer, neurodegeneration, and immune disorders. The complex interplay between ubiquitination and deubiquitination is a key determinant of cellular homeostasis and the intricate balance of signaling pathways.'
"

Proteins (6)

ProteinDefinitionTaxonomy
Probable ubiquitin carboxyl-terminal hydrolase FAF-XA probable ubiquitin carboxyl-terminal hydrolase FAF-X that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q93008]Homo sapiens (human)
Ubiquitin carboxyl-terminal hydrolase 13A ubiquitin carboxyl-terminal hydrolase 13 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92995]Homo sapiens (human)
Ubiquitin carboxyl-terminal hydrolase 13A ubiquitin carboxyl-terminal hydrolase 13 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92995]Homo sapiens (human)
Ubiquitin carboxyl-terminal hydrolase 8A ubiquitin carboxyl-terminal hydrolase 8 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P40818]Homo sapiens (human)
Serine hydroxymethyltransferase, mitochondrialA serine hydroxymethyltransferase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P34897]Homo sapiens (human)
26S proteasome non-ATPase regulatory subunit 14A 26S proteasome non-ATPase regulatory subunit 14 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O00487]Homo sapiens (human)

Compounds (19)

CompoundDefinitionClassesRoles
oxyquinolineOxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.

quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes.
monohydroxyquinolineantibacterial agent;
antifungal agrochemical;
antiseptic drug;
iron chelator
oxaprozinoxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
1,3-oxazoles;
monocarboxylic acid
analgesic;
non-steroidal anti-inflammatory drug
papaverinepapaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines
antispasmodic drug;
vasodilator agent
primaquineprimaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
aminoquinoline;
aromatic ether;
N-substituted diamine
antimalarial
8-aminoquinoline
8-methylquinolinemethylquinoline
flupirtineflupirtine: RN given refers to parent cpd without isomeric designationaminopyridine
duloxetineduloxetine
8-mercaptoquinoline8-mercaptoquinoline: structure given in first source
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
N-[7-(2-furanyl)-5-oxo-7,8-dihydro-6H-quinazolin-2-yl]acetamidequinazolines
pyrviniumpyrvinium : A quinolinium ion that is 1-methylquinolinium substituted by dimethylamino group at position 6 and a (E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl at position 2. It is a anthelminthic drug active against pinworms. The salts of pyrvinium can also be used as anticancer agents.

pyrvinium: RN given refers to parent cpd; synonyms vanquin & vankin refer to pamoate[2:1]; structure in Merck Index, 9th ed, #7810
quinolinium ionanthelminthic drug;
antineoplastic agent
2-(2-furanylmethyl)-3-[[2-(3-pyridinyl)-3H-benzimidazol-5-yl]amino]-3H-isoindol-1-oneisoindoles
gw2974GW2974: quinazoline derivative, which is able to block the activation of both the EGFR and erbB2pyridopyrimidine
degrasyndegrasyn: a JAK2 kinase inhibitor that induces rapid degradation of c-Myc protein in MM-1 multiple myeloma and other tumor cell lines; structure in first source
carfilzomibepoxide;
morpholines;
tetrapeptide
antineoplastic agent;
proteasome inhibitor
hbx 41108HBX 41,108: inhibits USP7 ubiquitin protease; structure in first source
belactosin abelactosin A: isolated from Streptomyces; structure in first source
spautin-1